Stocktoria

Pediatrix Medical Group, Inc. MD

NYSE · stock · Services-Hospitals · website · IPO 1995-09-20

Pediatrix Medical Group, Inc. statistics & valuation

P / E12.3×
P / S1.1×
P / B2.3×
Net margin8.6%
Return on capital11.7%
Graham number -20.6%$21.03

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($21.03); a green figure means the price is below it.

Profitability & efficiency

Net margin (%)
10.20% 9.80% 15.60% -84.20% -45.90% 6.90% 3.40% -3.00% -4.90% 8.60% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
18.00% 14.00% 14.40% 9.70% 5.70% 10.60% 8.80% 0.40% -3.40% 10.90% 2016201720182019202020212022202320242025
Return on equity (%)
11.80% 10.40% 8.70% -99.90% -106.50% 14.60% 7.40% -7.10% -13.00% 19.10% 2016201720182019202020212022202320242025
Shares outstanding
93.7M 93.7M 91.6M 84.2M 85.6M 86.4M 84.1M 84.0M 85.9M 85.4M 2016201720182019202020212022202320242025
Net debt ($)
$1.64B $1.81B $1.93B $1.59B $576.2M $602.3M $627.4M $548.9M $381.3M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
6.10% 5.50% 4.50% -36.10% -23.80% 4.80% 2.80% -2.70% -4.60% 7.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
0.62× 0.60× 0.64× 1.13× 2.27× 1.10× 0.71× 0.73× 0.80× 2016201720182019202020212022202320242025
EPS ($)
$3.49 $3.45 $2.93 -$17.83 -$9.55 $1.53 $0.79 -$0.73 -$1.19 $1.94 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

P / E vs its own history

Pediatrix Medical Group, Inc. trades at about 13.7× earnings — below its 10-year norm (10-year range 11×–21.3×, median 19.4×).

11× 21.3×

Shaded band = 10-year range (11×–21.3×); dot = today's 13.7×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin10.9%-3.4%0.4%8.8%10.6%5.7%9.7%14.4%14.0%18.0%
Net margin8.6%-4.9%-3.0%3.4%6.9%-45.9%-84.2%15.6%9.8%10.2%
Return on assets7.4%-4.6%-2.7%2.8%4.8%-23.8%-36.1%4.5%5.5%6.1%
Return on equity19.1%-13.0%-7.1%7.4%14.6%-106.5%-99.9%8.7%10.4%11.8%
Debt / equity0.80×0.73×0.71×1.10×2.27×1.13×0.64×0.60×0.62×
Current ratio1.661.471.241.001.973.491.351.311.181.31

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.